Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

Bimekizumab demonstrated a favorable safety profile for the long-term treatment of axSpA and PsA, with rates of TEAEs remaining stable over time.

This five-year analysis of the C-144-01 trial represents unprecedented durability and duration of follow-up in advanced melanoma patients previously treated with anti-PD-1 and targeted therapy, where ...

The empirical dietary inflammatory pattern (EDIP) score, used in the study to measure the inflammatory potential of patients' ...

Analysts at Truist Securities admitted that the result for itepekimab, which the companies were hoping to follow their ...

Partners Regeneron and Sanofi say itepekimab only achieved a significantly statistic result in one of two studies.

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...